ArticleInternational journal of molecular sciences2024

ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.

Lei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.